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Abstract
Background:
With the greater worldwide availability of neuroimaging, more intracranial arachnoid cysts (IACs) are being
found in all age groups. A subset of these lesions become symptomatic and requires neurosurgical
management. The clinical presentations of IACs vary from asymptomatic to extremely symptomatic. Here,
we reviewed the clinical presentation and treatment considerations for pediatric IACs.
Case Description:
Here, we presented three cases of IAC, focusing on different clinical and treatment considerations.
Conclusion:
IACs can be challenging to manage. There is no Class I Evidence to guide how these should be treated. We
suggest clinical decision-making framework as to how to treat IACs based on our understanding of the
natural history, risks/benefits of treatments, and outcomes in the future, require better patient selection for
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INTRODUCTION
Richard Bright first reported medical cases in 1831 involving intracranial arachnoid cysts (IACs). These
were found in patients from all age groups but mostly (75%) occurred in children.[9] IACs are composed of
arachnoidal fluid-filled cysts which usually do not communicate with the ventricular system.[38] The
majority are found incidentally and are generally considered asymptomatic; however, a subset of patients
become symptomatic and require neurosurgical intervention. Symptoms from IACs may include
headaches/increased intracranial pressure, hydrocephalus, local mass effect, or cyst rupture [Table 1]. Local
mass effect may contribute to focal neurological deficits dependent on the adjacent neural structures or bony
anatomy (e.g., cortical thinning of the bone or “glacial change”). These lesions can also rupture, causing
subdural hygromas or hemorrhage.
DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS FOR IACS
The growing availability of neuroimaging (MR, CT) worldwide has increased the frequency with which
IACs have been diagnosed. With CT cisternography, they may be defined as communicating or
noncommunicating with the subarachnoid space.[38] Treatment options include observation, medical
management with acetazolamide, and surgical management utilizing fenestration and/or shunting with or
without endoscopy.
EPIDEMIOLOGY
IACs occur in 2.6%of children and 1.4% of adults.[2,3] There is a male-to-female preponderance; ratios
range from 2:1 to 5:1.[2,4,14] There is an increased incidence of IACs in conjunction with multiple genetic
syndromes including autosomal-dominant polycystic kidney disease, acrocallosal, and Aicardi syndromes [
Table 2].[4] Although IACs occur throughout the neuroaxis, nearly half are found in the middle temporal
fossa (MTF). Other common locations include the posterior fossa, the suprasellar region, and occasionally
intraventricularly [Figures 1–4].[3,12] Most are incidental findings on neuroimaging studies (e.g., closed
head trauma or headaches) and are asymptomatic. In a large pediatric series, they reported a 6.8% incidence
of symptomatic IACs.[2]
ETIOLOGY/PATHOGENESIS
IACs are congenital lesions, of unknown etiology. Previously, they were thought to result from gestational
ischemic, traumatic, or infectious insults; these theories are no longer supported.[21,29,34] Others suggest
that IACs arise from a congenital splitting of arachnoid membrane layers during fetal development,
resulting in connected cerebrospinal fluid (CSF) entrapment and/or accumulation in this “potential space.”
A more recent viewpoint for middle fossa IACs is that it was a failure of the frontal and temporal embryonic
meningeal merging, resulting in a duplication within the Sylvian fissure.[36]
HISTOPATHOLOGY
Histopathologically, the arachnoid cyst (AC) wall consists of duplicated layers of normal arachnoid.
However, ultrastructural examination demonstrates a split layer of abnormal arachnoid tissue characterized
by hyperplastic arachnoid cells, increased collagen, and absence of the spider-like trabeculations
characteristic of normal arachnoid.[28]
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MECHANISMS OF IAC EXPANSION
Proposed mechanisms for IAC expansion include fluid diffusion down an osmotic gradient,[5,31] fluid
secretion by cyst-lining cells,[13,16] and/or a one-way ball-valve mechanism pushing fluid into the IAC
with CSF pulsations.[1,15,17,32] Halani et al. proposed a vessel-associated slit valve mechanism for IAC
expansion in four pineal region ACs.[15]
CT AND MR-IMAGING CHARACTERISTICS OF IACS
CT and MR studies demonstrate that IACs are well-circumscribed, extra-axial, simple cystic lesions. They
are isodense to CSF on CT, and isointense to CSF on all magnetic resonance image (MRI) sequences.
Unlike dermoid or epidermoid cysts, they do not exhibit diffusion restriction on MRI and are not lobulated
with heterogonous signal characteristic on MRI FLAIR imaging. Ruptured ACs can fill with blood products,
resulting in imaging studies reflecting progressive blood degradation pathways. Chronic subdural
hematomas or subdural hygromas can be isodense to CSF on CT. However, on MRI, they do not share
signal characteristics of CSF. Rather they demonstrate enhancing membranes and morphology distinct from
ACs (i.e., crescent-shaped layering along the cerebral convexities or layering along the falx or tentorium).
DIFFERENTIAL DIAGNOSTIC CONSIDERATIONS FOR IACS
Multiple other lesions must be differentiated for IACs. These include intraaxial cystic tumors (e.g., pilocytic
astrocytomas or hemangioblastomas) that typically have a solid and/or enhancing components.
Neurocystercercosis can also occur in the arachnoid space (racemose or “grape-like”) but usually comprises
multiple cysts. Other differential considerations include a mega cisterna magna and other non-neoplastic
cysts (e.g., neuroglial, neurenteric, or porencephalic cysts).[19,26]
GALASSI CLASSIFICATION OF MIDDLE TEMPORAL FOSSA IACS
MTF IACs account for more than half of all IACs [Figure 5]. The widely used Galassi Classification (1982)
provides a schematic radiological classification of these lesions [Table 3].[10] There are three types of MTF
IACs based on size and degree of mass effect. Type I cysts are characterized by the following: lens-shaped,
anterior tip of the MTF, freely communicate with CSF/surrounding subarachnoid space on MR-cine/CT-
ventriculography;[11] they rarely require surgery [Table 3]. Type II cysts are characterized by intermediate
size, more rectangular morphology, extend into the Sylvian fissure, have variable communication with CSF
pathways, and exert local mass effect on the temporal lobe; they occasionally and sometimes require
surgery. Type III cysts constitute the largest group, extend the full length of the Sylvian fissure, exert
significant mass effect (often with midline shift), and do not communicate with the subarachnoid space;
these usually require surgery.[4,10,38]
CLINICAL PRESENTATION: ASYMPTOMATIC VS. SYMPTOMATIC
Most IAC are asymptomatic and do not require surgery
Most IACs asymptomatic at presentation are incidental and do not require surgery; only 6.8% of large
pediatric series show these patients are symptomatic.[3] The overwhelming majority of IACs do not change
in size from the time of the initial diagnosis. These lesions only rarely expand in the pediatric population;
when they do occur, they are primarily found in children under 4 years of age.[20,23,25,27,30,33]
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SYMPTOMATIC HEMORRHAGE INTO IAC
Hemorrhage into IACs or rupture into the subdural space leading to subdural CSF hygroma or overt
subdural hemorrhage can occur. Hemorrhage rates in the pediatric population are rare (0.3–6%).[7,23] Risk
factors for hemorrhage include trauma and larger cyst size.[7,37] Although activity limitations for children
with known IAC are debatable, many neurosurgeons recommend abstaining from contact sports.[35]
MULTIPLE INDICATIONS FOR IAC SURGERY
In patients with symptomatic IACs, the following variables may contribute to the need for surgery: IAC
location, mass effect, impact on CSF flow dynamics (e.g., hydrocephalus), focal neurological deficits,
headaches, seizures, and developmental/cognitive deficits [Table 1].
Suprasellar IACs
Suprasellar IAC can result in compression of the hypothalamic–pituitary axis and thus in endocrinopathies,
or of the Foramen of Monroe resulting in obstructive hydrocephalus.
Tectal IACs
Tectal compression from quadrigeminal plate IACs may be responsible for Parinaud's syndrome and/or
obstructive hydrocephalus due to compressions of the Aqueduct of Sylvius.
CP angle and middle fossa IACs
Cerebellopontine angle IACs can cause progressive tinnitus, hearing loss, facial palsy, nystagmus, and/or
vertigo, whereas MTF IACs can cause temporal/cranial remodeling, deformity, and distortion of orbit with
proptosis. The decision for surgical intervention depends on the patient's symptomology.
TREATMENT APPROACH
The approach for treating IACs is summarized in Table 4.
SMALL ASYMPTOMATIC IACS: NO SURGERY
The protocol for patients with small, asymptomatic IACs is the observation with or without repeat imaging.
Symptomatic expansion occurs more commonly in children under 4 years or age; these patients warrant
serial imaging. For those over the age of 4, symptoms alone may be followed.
SURGICAL INDICATIONS FOR IACS
Surgery is indicated in patients with symptomatic progression associated with hydrocephalus, focal
neurological deficits, or localizable seizures. Additionally, large MTF cysts may remodel the overlying
frontal, temporal, parietal bones, and/or the orbit resulting in disfigurement. Here, surgery may arrest this
process and reduce associated symptoms (e.g., headaches).
DIAGNOSIS AND TREATMENT OF HEADACHES ASSOCIATED WITH IACS
IAC surgery for headaches remains controversial. Kershenovich and colleagues conducted a preoperative
trial of acetazolamide to determine who would benefit from surgery; it benefitted 16 of 17 patients (e.g. 13
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patients with resolution of symptoms, 3 improved).[18] Others have proposed invasive ICP monitoring to
select patients for IAC surgery; here, the evidence remains unclear.[8]
SEIZURES CORRELATED WITH IACS
Some patients with IACs present with seizures. Improved seizure localization may help determine whether
IAC surgery is warranted based upon video EEG monitoring, brain electrical source analysis,
magnetoencephalography, ictal SPECT imaging, and interictal PET imaging. IAC surgery for poorly
localized seizure activity remains controversial.
PROPHYLACTIC IAC SURGERY TO AVERT HEMORRHAGES
Prophylactic surgery has been proposed for very large IACs due to their increased risk of hemorrhage.
Unfortunately, there is a lack of data regarding the natural history of these lesions and hemorrhage rates;
prophylactic surgery, therefore, remains controversial.
SUBDURAL HYGROMA FROM IAC RUPTURE
IAC rupture can result in symptomatic subdural hygromas. They usually present within days to weeks
following a rupture, with progressive elevated ICP (e.g. headache, emesis, CN VI palsy, or papilledema).
Traditionally, surgery had been recommended in these patients.[6] There are, however, newer reports
question this strategy.[22]
SURGICAL OPTIONS
There is no consensus regarding the optimal surgery for IACs. Two major surgical options for IACs include
cyst shunting (cyst-peritoneal shunt) or cyst wall fenestration into surrounding CSF-filled spaces (cisterns or
ventricles). Subdural hygromas or hemorrhages may be associated with IAC, requiring burr hole drainage,
with/without fenestration or shunting.
CYST-PERITONEAL SHUNTING
Cyst-peritoneal shunting lowers ICP by CSF diversion, whereas fenestration does not change the CSF
volume. Such shunting allows for expansion of the brain parenchyma, but there is no clear benefit unless
there is elevated ICP. Nevertheless, this may result in shunt dependence along with its attendant
complications. Shunting to the ventricle or subdural space has also been reported in the literature, but data
regarding its safety/efficacy are limited.[9,24]
CYST FENESTRATION
IAC cyst fenestration avoids shunt-related issues and requires a small craniotomy or, more recently,
endoscopic fenestration. The open approach offers the increased ability to control bleeding and perform
surgery utilizing a bimanual microsurgical technique versus endoscopy.
BOTH SHUNTING AND CYST FENESTRATION OPTIONS FOR IACS
Fewel et al.[8] recommend both shunting and fenestration techniques for patients presenting with
hydrocephalus. Some surgeons favor fenestration, with shunting reserved for fenestration failure.
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CASE REPORTS SHORTEN AND CUT MARKEDLY
Case 1
A 14-month-old asymptomatic male, on CT, had a large left supratentorial hemispheric AC (12 × 5 cm,
Galassi type 3) [Figure 1a–c]. He was followed for 3–6 months with serial MRIs. At 6 months, he
developed mild papilledema and the MR showed slight enlargement of the AC. A cystoperitoneal shun was
placed. Eight-month postoperatively, the MRI demonstrated a significant reduction in the size of the AC,
with decreased mass effect, and reduced midline shift (14–4 mm) [Figure 1d–f]. He has remained
asymptomatic without papilledema for how long?
Case 2
A 4-year-old male presented with vomiting and headache attributed to a Galassi type 2 MR-documented left
middle fossa AC. Other comorbidities included global developmental delay (e.g., Trisomy 13 diagnosis),
left ventricular noncompaction cardiomyopathy, GERD, a seizure disorder, and tethered cord. A later MRI
showed further enlargement of the left middle cranial fossa AC (Galassi type 3) (6 months later) with
remodeling of the adjacent sphenoid wing and more mass effect (e.g. increased midline shift) [Figure 2a, b].
A lumbar puncture revealed an opening pressure of 43. A left temporal craniotomy was performed for
fenestration of the AC into the basal cisterns. Postoperatively, the patient dramatically improved (e.g.,
resolution of headaches and emesis). The MRI 1 year later showed a significant decrease in the AC size (2.8
cm × 3.6 m × 3.5 cm compared to 6 cm × 4 cm × 4.5 cm preop) with reduced mass effect. At 2
postoperative years, the AC size was further diminished [Figure 2c, d].
Case 3
A 12-year-old male presented with a 3-day history of severe headaches, blurry vision, and vomiting
following a helmet-to-helmet collision at football practice. The initial CT and MRI imaging were consistent
with a ruptured AC. These studies showed a large right middle cranial fossa AC (Galassi type 3), with
remodeling of the adjacent skull, mass effect on the adjacent brain with midline shift medially, and bilateral
4 mm subdural effusions overlying the cerebral hemispheres [Figure 3a–c]. He returned 3 weeks later with
symptoms of increased ICP, and studies now showed increased mass effect from the right subdural hygroma
with greater midline shift [Figure 3d–f]. An emergent cystoperitoneal shunt was placed. He developed
symptoms of overshunting, requiring shunt replaced with an external subdural drain. When severe
headaches worsened by clamping the subdural drain, a surgical AC fenestration into the subdural space and
basal subarachnoid cisterns was warranted. Transiently, a ventricular drain placed in the left large CSF
space was removed without incident remained normal. Although he continues to have mild chronic
headaches, he is now stable 3 years postoperatively [Figure 4a–c].
CONCLUSION
There is no Class I evidence regarding the optimal treatment of IACs. We must, therefore, weigh the risks
versus benefits of conservative versus surgical treatment of these lesions in symptomatic patients on an
individual patient basis.
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Range of presenting symptoms
Symptoms Mechanism/Notes
Symptoms attributable to mass
effect either from the IAC,






Can be obstructive HCP from compression at a
variety of places or nonobstructive HCP presumed to






Parinaud’s syndrome Tectal compression by quadrigeminal plate IAC
Glacial change (bony Typically, from MTF IACs resulting in cranial




asymmetry ranging from focal skull prominence to
disfiguring deformity with distortion of the nearby
orbit with proptosis
Endocrinopathy Compression of HPA structures by suprasellar IAC
Seizures Epileptogenicity localized to affected cortex
Nonspecific symptoms with
unclear relationship to IAC
Headache Headaches unable to be attributed to increased ICP





IAC=Intracranial arachnoid cysts; ICP=intracranial pressure; CPA=cerebellopontine angle
Table 2








ADPKD=Autosomal-dominant polycystic kidney disease
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Large arachnoid cyst occupying majority left anterior and middle cranial fossae (Case 1). (a–c) Axial, coronal, and sagittal,
respectively; coronal T2-weighted magnetic resonance imaging (MRI) of the brain demonstrating an arachnoid cyst
eliciting extensive mass effect and 1 cm rightward midline shift. (d–f) Corresponding T2-weighted MRI 8 months
postplacement of cystoperitoneal shunt demonstrating interval reduction of cyst size and corresponding midline shift
Figure 2
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Large left middle cranial fossa arachnoid cyst (Case 2). (a and b) Axial and sagittal T1-weighted magnetic resonance
imaging (MRI) of the brain demonstrating an arachnoid cyst eliciting extensive mass effect with sphenoid wing remodeling
and distal left MCA branch displacement. (c and d) Axial and sagittal T1-weighted MRI of the brain 2 years after arachnoid
cyst fenestration into the basal cisterns, displaying interval reduction in cyst size and decreased mass effect
Figure 3
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Previously asymptomatic right middle and anterior cranial fossae archnoid cyst with subdural fluid collection (Case 3). (a
and b) Coronal and sagittal T1-weighted magnetic resonance imaging (MRI) performed secondary to trauma demonstrated
a previously asymptomatic archnoid cyst of the right anterior an middle cranial fossae. (c) Axial T2 MRI revealed small
bilateral hemisphere CSF-isointense subdural fluid collections suggestive of cyst rupture. (d–f) Coronal, sagittal, and axial
T2-weighted MRI performed on presentation to the emergency department 3 weeks after initial trial of conservative
treatment. Interval development of extensive right hemisphere hygroma was seen producing midline shift with compression
of the lateral ventricle
Figure 4
Right middle and anterior fossae arachnoid cyst with surgical resolution of traumatic hygroma (Case 3). Despite attempted
management of hygroma development with cystoperitoneal shunt, symptoms persisted necessitating surgical fenestration of
cyst walls, and regular follow-up was maintained. (a) Coronal T2-weighted magnetic resonance imaging (MRI) of the brain
performed at 3 years postoperative follow-up demonstrated reabsorption of right hemisphere hygroma. (b) Sagittal T1-
weighted MRI revealed interval reduction in arachnoid cyst-induced mass effect with reexpansion of cerebral sulci. (c)
Axial T2-weighted MRI illustrated resolution of midline shift and relief of compression of the lateral ventricle
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Figure 5
The incidence of arachnoid cysts in 309 children drawn from a sample of 11,738 consecutive MR imaging studies
(Modified from Al-Holou WN, Yew AY, Boomsaad ZE, Garton HJ, et al. Prevalence and natural history of arachnoid cysts
in children. J Neurosurg Pediatr 2010;5: 578-85)
Table 3
Galassi classification of middle cranial fossa arachnoid cysts





Limited to the anterior portion of the middle cranial












Large, fills the whole
middle cranial fossa
Displacement of not only the temporal lobe but also the
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Management Reason for surgery/notes




Surgery controv ersial Headaches, nonlocalized seizures, developmental delay
Asymptomatic,
large
Surgery controversial Theorized increased hemorrhage risk of large IACs
Asymptomatic,
small
Observation±repeat imaging Likely no need for repeat imaging after 4 years of age




Surgery or expectant management
depending on symptoms severity
Usually present with symptoms of elevated ICP, can
have benign natural history with spontaneous resolution
Articles from Surgical Neurology International are provided here courtesy of Wolters Kluwer -- Medknow
Publications
